183 related articles for article (PubMed ID: 28594717)
1. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
Kwaan MR; Fan Y; Jarosek S; Elliott SP
Dis Colon Rectum; 2017 Jul; 60(7):682-690. PubMed ID: 28594717
[TBL] [Abstract][Full Text] [Related]
2. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
[TBL] [Abstract][Full Text] [Related]
3. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
Modrek AS; Hsu HC; Leichman CG; Du KL
Radiat Oncol; 2015 Apr; 10():101. PubMed ID: 25902707
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
6. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years.
Wang L; Li YH; Cai Y; Zhan TC; Gu J
Clin Colorectal Cancer; 2016 Jun; 15(2):152-7. PubMed ID: 26508595
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
Bhangu A; Kiran RP; Audisio R; Tekkis P
Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
[TBL] [Abstract][Full Text] [Related]
8. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
9. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy.
Manyam BV; Mallick IH; Abdel-Wahab MM; Reddy CA; Remzi FH; Kalady MF; Lavery I; Koyfman SA
J Gastrointest Surg; 2015 Sep; 19(9):1676-83. PubMed ID: 26014718
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
12. Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older.
Wan JF; Zhu J; Li GC; Sun WJ; Zhang Z
Oncotarget; 2015 Oct; 6(30):30377-83. PubMed ID: 26160846
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
14. Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China.
Qin Q; Huang B; Cao W; Zhou J; Ma T; Zhou Z; Wang J; Wang L
Dis Colon Rectum; 2017 Jul; 60(7):697-705. PubMed ID: 28594719
[TBL] [Abstract][Full Text] [Related]
15. Population-based assessment of the surgical management of locally advanced colorectal cancer.
Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
[TBL] [Abstract][Full Text] [Related]
16. New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men.
Wallis CJ; Mahar A; Cheung P; Herschorn S; Klotz LH; Al-Matar A; Kulkarni GS; Lee Y; Kodama RT; Narod SA; Nam RK
Eur Urol; 2016 May; 69(5):933-41. PubMed ID: 26572707
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of outcome in relation to the type of resection in rectal cancer.
Ortiz H; Wibe A; Ciga MA; Kreisler E; Garcia-Granero E; Roig JV; Biondo S;
Dis Colon Rectum; 2014 Jul; 57(7):811-22. PubMed ID: 24901681
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Risk of Bowel-Related Quality-of-Life Impairment After Restorative Resection for Rectal Cancer: A Multicenter Cross-Sectional Study.
Battersby NJ; Juul T; Christensen P; Janjua AZ; Branagan G; Emmertsen KJ; Norton C; Hughes R; Laurberg S; Moran BJ;
Dis Colon Rectum; 2016 Apr; 59(4):270-80. PubMed ID: 26953985
[TBL] [Abstract][Full Text] [Related]
19. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
